Scynexis (SCYX) Capital Expenditures Growth (1y) (2014 - 2021)
Scynexis (SCYX) Capital Expenditures Growth (1y) (2014 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 32.28% |
| 3 | Zoetis | 32.68 Bn | 30.74 Bn | 1.62 Bn | -38.20% |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn | -15.72% |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn | 32.98% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.34 Bn | 18.54 Bn | 1.16 Bn | -6.34% |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | -86.92% |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | -21.54% |
| 10 | Scynexis | 23.34 Mn | -13.41 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -11,850.00% |
| Sep 30, 2021 | 5,775.00% |
| Mar 31, 2018 | 400.00% |
| Mar 31, 2017 | -85.71% |
| Dec 31, 2016 | -92.86% |
| Sep 30, 2016 | -50.00% |
| Mar 31, 2016 | -91.81% |
| Dec 31, 2015 | -41.67% |
| Sep 30, 2015 | -93.53% |
| Jun 30, 2015 | 42.97% |
| Mar 31, 2015 | 131.08% |
| Dec 31, 2014 | 18.03% |
| Sep 30, 2014 | 442.11% |
| Jun 30, 2014 | 429.79% |
| Mar 31, 2014 | -72.18% |